Alexion Pharmaceuticals Inc $169.29

up +0.98


29/8/2014 04:00 PM  |  NASDAQ : ALXN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get ALXN Trend Analysis - it has outperformed the S&P 500 by 33%

Partner Headlines

  1. Stocks Hold Decent Gains; InterMune Deal Sparks Biotechs

    IBD
  2. UPDATE: 8-K from Alexion Pharma Shows FDA Issued Form 483 at Aug. Inspection ...

    Benzinga
  3. Alexion Initiates Multinational Registration Trial of Eculizumab for Prevention ...

    Benzinga
  4. Jazz, Celgene Lead Top 4 Drugmaker Profit Margins

    IBD
  5. Alexion CEO Receives Nearly $17 Million for Sale of Company Stock

    GuruFocus
  6. GW Pharma, Insys Face Off In Cannabis Drug Space

    IBD
  7. Here's How Facebook, Alexion Teach Lessons In Tenacity

    IBD
  8. European Commission Grants Orphan Drug Designation To Soliris (eculizumab) ...

    Benzinga
  9. Many Leading Stocks Damaged As Market Tumbles Broadly

    IBD
  10. Stocks Feint Higher, Then Slip; Pending Home Sales Down In June

    IBD
  11. Biotechs Fall Despite Beats

    IBD
  12. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD
  13. Celgene, Alexion Earnings Top Street, But Stocks Fall

    IBD
  14. Stocks Up And Down At Open; Under Armour, Facebook Surge

    IBD
  15. US Stock Futures Gain Ahead Of Earnings, Economic Data

    Benzinga
  16. Biogen, Gilead Crush Earnings Estimates On Hot Drugs

    IBD
  17. S&P 500 Posts New High; Biotechs, Airlines, Builders Up

    IBD
  18. S&P 500 Aims At New High; Biotechs Gap Up In Fast Trade

    IBD
  19. Biogen Trounces Q2 Estimates As Tecfidera Outperforms

    IBD
  20. Alexion, 3 Other Top Biotechs Reporting Earnings

    IBD
  21. Stocks Climb In Solid Trade; Chipotle Gaps Up, Breaks Out

    IBD
  22. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  23. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  24. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  25. Will New Drug Give Alexion Pharmaceuticals A Boost?

    IBD
  26. Biogen's Profit Rolls Amid Recent Drug Launches

    IBD
  27. Inside The IBD 50: Leaders Show Mixed Action

    IBD
  28. Alexion Pharma Looks To Life Beyond Its Blockbuster

    IBD
  29. Raptor Announces CEO Succession Plan; Dr. Christopher Starr To Retire As ...

    Benzinga
  30. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  31. 4 Biotech Stocks Worth A Look Ahead Of FDA Approvals

    Benzinga
  32. Stocks Mixed As Losses Pared; Foot Locker Steps Up

    IBD
  33. Growth Stocks Kick Into Gear In Latest IBD 50 Screen

    IBD
  34. Techs, Small Cap Stocks Lead; Family Dollar Heads Group Rally

    IBD
  35. After The Biotech Sell-off, How Will Investors Treat Alexion Pharmaceuticals?

    IBD
  36. Alexion, Priceline, OpenTable: A Top Manager's View

    IBD
  37. Market Wrap For May 5: Dow Erases Triple-Digit Loss, All Three Major Indices ...

    Benzinga
  38. US Stock Futures Decline After China Data

    Benzinga
  39. Earnings Growth Anemic But Medical Sector Healthy

    IBD
  40. Kors Among 5 Stocks With Superior 3-Year EPS Growth

    IBD
  41. Amgen Blazed Biotech Trail, Earned 165,233% Reward

    IBD
  42. Alexion Tops, Celgene Mixed

    IBD
  43. Stocks Mixed In Late Trade; Goodyear Breaks Out

    IBD
  44. Nasdaq Leads As Indexes Reverse Upward

    IBD
  45. Alexion, Celgene Report Contrasting Q1 Earnings

    IBD
  46. US Stock Futures Surge After Upbeat Apple Earnings

    Benzinga
  47. US Stock Futures Edge Lower Ahead Of Earnings

    Benzinga
  48. A Drill Can Help Identify Right Time To Sell Leaders

    IBD
  49. Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

    IBD
  50. Facebook, Walgreen Climb Monday On International News

    IBD
Trading Center